Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 12, Issue 2, Pages 512-518
Publisher
Informa UK Limited
Online
2015-08-21
DOI
10.1080/21645515.2015.1076598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994–2010
- (2015) Piraya Bhoomiboonchoo et al. BMC PUBLIC HEALTH
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study
- (2015) Joseph Torresi et al. VACCINE
- Economic and Disease Burden of Dengue Illness in India
- (2014) Donald S. Shepard et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil
- (2013) Gustavo H. Dayan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand
- (2013) Kathryn B. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study
- (2013) Amar-Singh HSS et al. VACCINE
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Fifty years of dengue in India
- (2012) Anita Chakravarti et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Dengue fever is massively under-reported in India, hampering our response
- (2012) M. Kakkar BMJ-British Medical Journal
- Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years
- (2012) Yee Sin Leo et al. Human Vaccines & Immunotherapeutics
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
- (2011) Rosario Z. Capeding et al. VACCINE
- Economic burden of dengue infections in India
- (2008) Pankaj Garg et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search